Risk Profiling of the Occupational Exposure of COVID-19 to Healthcare Workers.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04477213|
Recruitment Status : Not yet recruiting
First Posted : July 20, 2020
Last Update Posted : December 10, 2020
|Condition or disease|
|COVID19 Healthcare Workers|
Risk of transmission of COVID-19 virus to healthcare workers (HCWs) is matter of debate since the start of this pandemic. In absence of adequate research, the transmission risk is based on non-human studies, non-HCWs epidemiological studies and experiences from previous pandemics or epidemics. The true magnitude of the risk to HCWs has not been clearly estimated. In absence of good scientific data, general recommendations create confusion and mistrust among HCWs. Besides lots of myth and misconceptions among the HCWs including physician adds to emotional and physical challenge in reduction of nosocomial transmission of COVID-19.
COVID-19 related lockdowns have disrupted the global supply-chain and good quality personal protective equipment (PPE) has become an intense matter of discussion from the start of pandemic. The rational use of PPE has become necessity to ensure sustained supply to those who need it in the frontline. In absence of reliable risk assessment and management based on true incidence calculation leads to either inadequate or overestimation of risk and unjustified use of PPE. The reported global data for occupational risk of COVID -19 for HCW varies greatly but it is reported to be higher than general populations. However, many of these studies has significant limitations, like inadequate risk assessment, community transmission is not accounted or all HCWs not included for analysis.
The investigators propose to conduct a retrospective study to define and quantify the variable occupational and non-occupational risk among various HCWs, to determine the rates of acquisition in the context of level of PPE use and other infection control measures recommended for COVID-19 and also to define the risk of secondary disease transmission to other household members of participants.
|Study Type :||Observational|
|Estimated Enrollment :||600 participants|
|Official Title:||Risk Profiling of the Occupational Exposure of COVID-19 to Healthcare Workers- A Multicentric Retrospective Study|
|Estimated Study Start Date :||January 15, 2021|
|Estimated Primary Completion Date :||February 15, 2021|
|Estimated Study Completion Date :||February 15, 2021|
- Rate of COVID-19 in healthcare workers (HCWs) [ Time Frame: 6 months ]
Positive HCW divided by total exposed HCWs in that category X 100 Rate will be calculated in 4 different categories.
- Front line HCWs (doctors, nurses, respiratory therapist, physiotherapist, dialysis technician, patient assistant etc)
- Front line support staffs (Customer care, pharmacist, billing assistance, ambulance driver etc.),
- Clinical support staffs- (dietician, food service worker, laundry worker, housekeeping staffs, health record staffs- infection control team etc.)
- Non-clinical support staffs- (Administrative support staff.)
- clinical severity of infection in HCWs [ Time Frame: Within 28 days of illness. ]
WHO Ordinal scale
- Uninfected No clinical or virological evidence of infection Score 0
- Ambulatory : No limitation of activities Score 1, Limitation Score 2.
- Hospitalised(Mild disease): No oxygen Score 3, Nasal prongs or Mask Score 4
- hospitalised (Severe disease): noninvasive ventilation/high flow nasal canula- score 5, Intubation and mechanical ventilation Score 6, mechanical ventilation and any other oxygen support like vasopressors Score 7
- dead score 8
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04477213
|Contact: Prashant Nasa, MD EDIC FNBemail@example.com|
|Contact: Surjaya Upadhyay, MDfirstname.lastname@example.org|
|Principal Investigator:||Helen King, RN DMS MBA||Senior Vice President: Nursing & Quality Corporate Quality & Nursing|